Brand new Solid Form Co-Crystals and Amorphous Focus Morning at the Pharmaceutical Co-Crystals and Amorphous Material 2012 Summits

LONDON, September 4, 2012 /PRNewswire/ –

Pharma IQ recently launched its 2012 Pharmaceutical Co-Crystals and Amorphous
Materials Summit programmes, featuring a brand new Solid Form Co-Crystals and Amorphous
Focus Morning. This Focus Morning is aim to discovery the overlapping and discuss crucial
areas that are involved in both, as well as to give participants as much input and
expertise from across both areas in one space.

The Solid Form Co-Crystals and Amorphous Focus Morning features case studies and
interactive sessions on the effective characterisation of co-crystals and amorphous. From
the discriminatory analysis on dissolution behaviour of several disordered/amorphous forms
to amorphous fractions in crystalline materials. These topics will help participants to
understand structure and dynamics in pharmaceutical solids.

Four professors from UK’s leading labs will lead roundtable discussions which will
cover pressing questions about the future application of co-crystals and amorphous
techniques both in pharmaceuticals and outside, the latest developments affecting
bioavailability and the FDA policy of solid form.

In addition to the Focus Morning, the 2012 summit programme will assess the clinical
application of co-crystals and amorphous forms into the manufacturing scale up process,
focus on developing and forming effective co-crystals and amorphous designs throughout the
phases of development and utilise novel methods of formulation identification to improve
drug efficacy, reduce cost of development and expedite time to market.

With the release of the new FDA draft guidance on classification of solid form and the
regulatory implications of this classification, it is crucial to learn the newest and most
innovative developments in characterisation, predictability, processing as well as the
legal and regulatory challenges.

Taking place from 25th to 26th September, Pharmaceutical Co-Crystals and Amorphous
Materials summits will be co-located at the Ramada Apollo Amsterdam, Netherlands willoffer
unparalleled knowledge and networking opportunities for researchers, pharmacist
specialists and formulation scientists to discuss practical approaches and give
participants take way top tips for future drug development in the solid state field.

Further information about Pharmaceutical Co-Crystals 2012 Summit is available on the
summit website at bit.ly/OgGOab
[http://www.pharmacocrystals.com/Event.aspx?id=771290&utm_campaign=PR&utm_medium=PR&utm_source=pharmacocrystals.com&utm_content=PR&utm_term=home&MAC=11377.006_PR ]
. For information
about the Pharmaceutical Amorphous Materials summit, please visit bit.ly/OQH4Q2
[http://www.pharmaamorphous.com/Event.aspx?id=772888&utm_campaign=PR&utm_medium=PR&utm_source=pharmaamorphous.com&utm_content=PR&utm_term=home&MAC=11377.006_PR ]
. Visitors can also
access the online resources centre for the latest news and developments of co-crystals and
amorphous materials techniques.

SOURCE Pharma IQ